The decision in 1987 by the pharmaceutical firm Merck & Co. to provide
Mectizan®(ivermectin) free of charge to river blindness control programs has challenged the …

Human onchocerciasis (river blindness) occurs in 13 foci distributed among six countries in
Latin America (Brazil, Colombia, Ecuador, Guatemala, Mexico and Venezuela), where about …

Abstract The Onchocerciasis Elimination Program for the Americas (OEPA) is a regional
initiative and international partnership that has made considerable progress toward its goal …

Les lignes directrices de l'OMS relatives à la certification de l'élimination de l'onchocercose
ont été publiées en 2001. Elles recommandent que, dans les zones où la transmission a été …

The Onchocerciasis Elimination Program for the Americas (OEPA) is a regional initiative
working towards the goal of eliminating morbidity and transmission of the filarial parasitic …

Onchocerciasis (river blindness) is a blinding parasitic disease that threatens the health of
approximately 120 million people worldwide. While 99% of the population at-risk for …

Background Onchocerciasis is a chronic parasitic infection originally endemic in 13 discrete
regional foci distributed among six countries of Latin America (Brazil, Colombia, Ecuador …

406 MMWR/May 24, 2013/Vol. 62/No. 20 the program began conducting MDA quarterly in
66 hyperendemic communities in the South and Northeastern foci, eventually extending this …

Onchocerciasis has historically been one of the leading causes of infectious blindness
worldwide. It is endemic to tropical regions both in Africa and Latin America and in the …

There are now three endemic foci of onchocerciasis in Mexico, all located in mountainous
areas in the south-east: two in the state of Chiapas and one in the state of Oaxaca. Together …